chap 49: Men as patients

Question 1

1. The factor that has the greatest effect on males developing male sexual characteristics is:
2. Cultural beliefs
3. Effective male role models
4. Adequate intake of testosterone in the diet
5. Androgen production

Answer 1

4.

Androgen production

Question 2

2. When assessing a male for hypogonadism prior to prescribing testosterone replacement, serum testosterone levels are drawn:
3. Without regard to time of day
4. First thing in the morning
5. Late afternoon
6. In the evening

Answer 2

2. First thing in the morning

Question 3

3. Some research supports that testosterone replacement therapy may be indicated in which of the following diagnoses in men?
4. Age-related decrease in cognitive functioning
5. Metabolic syndrome
6. Decreased muscle mass in aging men
7. All of the above

Answer 3

4. All of the above

Question 4

4. The goal of testosterone replacement therapy is:
5. Absence of all hypogonadism symptoms
6. Testosterone levels in the mid-normal range 1 week after an injection
7. Testosterone levels in the mid-normal range just prior to the next injection
8. Avoidance of high serum testosterone levels during therapy

Answer 4

2. Testosterone levels in the mid-normal range 1 week after an injection

Question 5

5. While on testosterone replacement, hemoglobin and hematocrit levels should be monitored. Levels suggestive of excessive erythrocytosis or abuse are:
6. Hemoglobin 14 g/dl or hematocrit 39%
7. Hemoglobin 11.5 g/dl or hematocrit 31%
8. Hemoglobin 13 g/dl or hematocrit 38%
9. Hemoglobin 17.5 g/dl or hematocrit 54%

Answer 5

4. Hemoglobin 17.5 g/dl or hematocrit 54%

Question 6

6. Monitoring of an older male patient on testosterone replacement includes:
7. Oxygen saturation levels at every visit
8. Serum cholesterol and lipid profile every 3 to 6 months
9. Digital rectal prostate screening exam at 3 and 6 months after starting therapy
10. Bone mineral density at 3 months and 6 months after starting therapy

Answer 6

3. Digital rectal prostate screening exam at 3 and 6 months after starting therapy

Question 7

7. When prescribing phosphodiesterase type 5 (PDE-5) inhibitors such as sildenafil (Viagra) patients should be screened for use of:
8. Statins
9. Nitrates
10. Insulin
11. Opioids

Answer 7

2. Nitrates

Question 8

8. Men who are prescribed phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction should be educated regarding the adverse effects of the drug which include:
9. Hearing loss
10. Hypotension
11. Delayed ejaculation
12. Dizziness

Answer 8

1. Hearing loss

Question 9

9. Male patients who should not be prescribed phosphodiesterase type 5 (PDE-5) inhibitors include:
10. Diabetics
11. Those who have had an acute myocardial infarction in the past 6 months
12. Patients who are deaf
13. Patients under age 60 years of age

Answer 9

2. Those who have had an acute myocardial infarction in the past 6 months

Question 10

10. Monitoring of male patients who are using phosphodiesterase type 5 (PDE-5) inhibitors includes:
11. Serum fasting glucose levels
12. Cholesterol and lipid levels
13. Blood pressure
14. Complete blood count

Answer 10

3. Blood pressure